Retaglutide is a novel GLP-1 receptor agonist currently under investigation for the management of obesity. This therapy works by stimulating the effects of glucagon-like peptide-1 (GLP-1), a naturally occurring hormone https://theoxftx912271.fitnell.com/79812502/retaglutide-a-promising-glp-1-receptor-agonist